Effectiveness of Canakinumab Treatment in Colchicine Resistant Familial Mediterranean Fever Cases

• Главные авторы: Burcu Bozkaya Yücel (Автор), Ozlem Aydog (Автор), Hulya Nalcacioglu (Автор), Ayşegül Yılmaz (Автор)
• Формат: ‌
• Опубликовано: Frontiers Media S.A., 2021-09-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Anti-interleukin 1 agents are used successfully in colchicine-resistant or intolerant Familial Mediterranean Fever (FMF) patients. Sixty-five patients with FMF who received canakinumab treatment for at least 6 months due to colchicine resistance or intolerance between 2016 and 2020 in our department...